Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B

European Journal of Immunology

Volumn 28, Issue 1, 1998, Pages 57-69

  Häusler, Peter ^a   Papoff, Giuliana ^a   Eramo, Adrians ^a   Reif, Karin ^b   Cantrell, Doreen A ^b   Ruberti, Giovina ^a  

^a CNR   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Apoptosis; CD95; Phosphatidylinositide 3 kinase; Protein kinase B

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTIBODY; CELL RECEPTOR; FAS ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; WORTMANNIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; ANTIGENS, CD95; APOPTOSIS; ARABIDOPSIS PROTEINS; CHROMONES; COS CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FATTY ACID DESATURASES; HL-60 CELLS; HUMANS; LEUKEMIA, T-CELL; MAST-CELL SARCOMA; MEMBRANE GLYCOPROTEINS; MICE; MORPHOLINES; PLANT PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; TRANSFECTION;

EID: 0039058167     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199801)28:01<57::AID-IMMU57>3.0.CO;2-8     Document Type: Article

References (80)

1. Nagata, S., Apoptosis by Death Factor. Cell 1997. 88: 355-365.
2. Chinnaiyan, A. M. and Dixit, V. M., The cell-death machine. Curr. Biol. 1996. 6: 555-562.
3. Fraser, A. and Evan, G., A license to kill. Cell 1996. 85: 781-784.
4. Cleveland, J. L. and Ihle, J. N., Contenders in FasL/TNF Death signaling. Cell 1995. 81: 479-482.
5. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. and Peter, M. E., Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995. 14: 5579-5588.
6. Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H. and Peter, M. E., FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 1997. 16: 2794-2804.
7. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. and Dixit, V. M., FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995. 81: 505-512.
8. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H. and Wallach, D., A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 1995. 270: 7795-7798.
9. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E. and Dixit, V. M., FLICE, a novel FADD-homologous ICE/CED-3-like Protease, is recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex. Cell 1996. 85: 817-827.
10. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. and Wallach, D., Involvement of MACH, a novel MORT1/FADD-interacting Protease, in Fas/APO-1 and TNF Receptor-Induced Cell Death. Cell 1996. 85: 803-815.
11. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W. and Yuan, J., Human ICE/CED-3 Protease Nomenclature. Cell 1996. 87: 171.
12. Martin, S. J. and Green, D. R., Protease activation during apoptosis: death by a thousands cuts? Cell 1995. 82: 349-352.
13. Kumar, S. and Lavin, M. F., The ICE family of cysteine proteases as effectors of cell death. Cell Death Differ. 1996. 3: 255-267.
14. Testi, R., Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 1996. 21: 468-471.
15. Skowronski, E. W., Kolesnick, R. N. and Green, D. R., Fas-mediated apoptosis and sphingomyelinase signal transduction: the role of ceramide as a second messenger for apoptosis. Cell Death Differ. 1996. 3: 171-176.
16. Hannun, J. A., Functions of Ceramide in coordinating cellular responses to stress. Science 1996. 274: 1855-1859.
17. Krammer, P. H., Dhein, Y., Valczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Baumler, C., Hellbardt, S., Germer, M., Peter, M. E. and Debatin, K.-M., The role of APO-1 mediated apoptosis in the immune system. Immunol. Rev. 1994. 142: 175-191.
18. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1456.
19. Suzuki, A., Enari, M., Eguchi, Y., Matsuzawa, A., Nagata, S., Tsujimoto, Y. and Iguchi, T., Involvement of Fas in regression of vaginal epithelia after ovariectomy and during an estrous cycle. EMBO J. 1996. 15: 211-215.
20. Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R. and Galluzzi, A., Potential involvement of Fas and its Ligand in the pathogenesis of Hashimoto's Thyroiditis. Science 1997. 275: 960-963.
21. Owen-Schaub, L. B., Yonehara, S., Crump, W. L. and Grimm, E. A., DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 1992. 140: 197-205.
22. Klas, C., Debatin, K.-M., Jonker, R. R. and Krammer, P. H., Activation interferes with the APO-1 pathways in mature human T cells. Int. Immunol. 1993. 5: 625-630.
23. Boise, L. H., Noel, P. J. and Thompson, C. B., CD28 and apoptosis. Curr. Opin. Immunol. 1995. 7: 620-625.
24. Foote, L. C., Howard, R. G., Marshak-Rothstein, A. and Rothstein, T. L., IL-4 induces Fas resistance in B cells. J. Immunol. 1996. 157: 2749-2753.
25. Carpenter, C. L. and Cantley, L. C., Phosphoinositide Kinase. Curr. Opin. Cell Biol. 1996. 8: 153-158.
26. Yao, R. and Cooper, G. M., Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995. 267: 2003-2006.
27. Minshall, C., Arkins, S., Freund, G. G. and Kelley, K. W., Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 1996. 156: 939-947.
28. Parrizas, M., Saltiel, A. R. and LeRoith, D., Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 1997. 272: 154-161.
29. Scheid, M. P., Lauener, R. W. and Duronio, V., Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signaling between interleukin-3 and granulocyte-macrophage colony stimulating factor. Biochem. J. 1995. 312: 159-162.
30. Franke, T. F., Kaplan, D. R. and Cantley, L. C., PI3K: downstream AKTion blocks apoptosis. Cell 1997. 88: 435-437.
31. Kauffmann-Zeh, A., Rodriguez-Viciana, P., Ulrich, E., Gilbert, C., Coffer, P., Downward, J. and Evan, G., Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997. 385: 544-548.
32. Strasser, A., Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. Curr. Opin. Immunol. 1995. 7: 228-234.
33. Yang, E. and Korsmeyer, S. J., Molecular Thanatopsis: a discourse on the Bcl2 family and cell death. Blood 1996. 15: 386-401.
34. Golstein, P., Controlling cell death. Science 1997. 275: 1081-1082.
35. Ui, M., Okada, T., Hazeki, K. and Hazeki, O., Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 1995. 20: 303-307.
36. Vlahos, C. J., Matter, W. F., Hui, K. Y. and Brown, R. F., A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994. 269: 5241-5248.
37. Reif, K., Nobes, C. D., Thomas, G., Hall, A. and Cantrell, D. A., Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 1996. 6: 1445-1455.
38. Chinnaiyan, A. M., O'Rourke, K., Yu, G.-L., Lyons, R. H., Garg, M., Duan, D. R., Xing, L., Gentz, R., Ni, J. and Dixit, V. M., Signal transduction by DR3 a death domain containing receptor related to TNFR1 and CD95. Science 1996. 274: 990-992.
39. 7056K activation mediated by phosphatidylinositol-3-OH kinase. Nature 1994. 370: 71-75.
40. Coffer, P. J. and Woodgett, J. R., Molecular-cloning and characterization of a novel putative protein-serine kinase related to the cAMP-dependent and protein-kinase-C families. Eur. J. Biochem. 1991. 201: 475-481.
41. Jones, P. F., Jacubowicz, T., Pitossi, F. J., Maurer, F. and Hemmings, B. A., Molecular-cloning and identification of a serine threonine protein-kinase of the 2nd-messenger subfamily. Proc. Natl. Acad. Sci. USA 1991. 88: 4171-4175.
42. Bellacosa, A., Testa, J. R., Staal, S. P. and Tsichilis, P. N., A retroviral oncogene, AKT, encoding a serine-threonine kinase containing and SH2-like region. Science 1991. 254: 244-247.
43. Chung, J., Kuo, C. J., Crabtree, G. R. and Blenis, J., Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70kdS6 protein kinase. Cell 1992. 69: 1227-1236.
44. Burgering, B. M. and Coffer, P. J., Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995. 376: 599-602.
45. Franke, T. F., Yang, S. I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R. and Tsichilis, P. N., The protein kinase encoded by the Akt protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 1995. 81: 727-736.
46. Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovic, M. and Hemmings, B. A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995. 378: 785-789.
47. Kohn, A. D., Kovacina, K. S. and Roth, R. A., Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 1995. 14: 4288-4295.
48. Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B. A., Mechanism of activation of protein-kinase B by insulin and IGF-1. EMBO J. 1996. 15: 6541-6551.
49. phox by a membrane-targeted phosphoinositide 3-kinase. Curr. Biol. 1996. 6: 1271-1278.
50. Klippel, A., Reinhard, C., Kavanaugh, W. M., Apell, G., Escobedo, M. A. and Williams, L. T., Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol. 1996. 16: 4117-4127.
51. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R. and Greenberg, M. E., Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997. 275: 661-665.
52. Thompson, C. B., Apoptosis in the pathogenesis and treatment of disease. Science 1995. 267: 1456-1462.
53. Nakanishi, S., Catt, K. J. and Balla, T., A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc. Natl. Acad. Sci. USA 1995. 92: 5317-5321.
54. Cross, M. J., Stewart, A., Hodgkin, M. N., Kerr, D. J. and Wakelam, M. J., Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 1995. 270: 25352-25355.
55. Brunn, G. J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence Jr, J. C. and Abraham, R. T., Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996. 15: 5256-5267.
56. Cascino, I., Papoff, G., De Maria, R., Testi, R. and Ruberti, G., Fas/Apo-1/CD95 receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 1996. 156: 13-17.
57. Franke, T. F., Kaplan, D. R., Cantley, L. C. and Toker, A., Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-biphosphate. Science 1997. 275: 665-668.
58. Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B. and Cohen, P., Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 1997. 7: 261-269.
59. Konishi, M., Matsuzaki, H., Tanaka, M., Ono, Y., Tokunaga, C., Kuroda, S. and Kikkawa, U., Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 1996. 93: 7639-7643.
60. Eldar-Finkelman, H., Seger, R., Vandenheede, J. R. and Krebs, E. G., Inactivation of Glycogen Synthase Kinase-3 by Epidermal Growth Factor is mediated by Mitogen-activated Protein Kinase/p90 Ribosomal Protein S6 Kinase signaling pathway in NIH/3T3 cells. J. Biol. Chem. 1995. 270: 987-990.
61. Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P. and Crabtree, G. R., Nuclear export of NF-ATc enhanced by Glycogen Synthase Kinase-3. Science 1997. 275: 1930-1933.
62. Welsh, G. I., Miyamoto, S., Price, N. T., Safer, B. and Proud, C. G., T cell activation leads to rapid stimulation of translation initiation factor IF2B and inactivation of glycogen synthase kinase-3. J. Biol. Chem. 1996. 271: 11410-11413.
63. Flanagan, W. M., Corthesy, B., Bram, R. J. and Crabtree, G. R., Nuclear association of a T-cell transcription factor blocked by FK-506 and Cyclosporin A. Nature 1991. 352: 803-807.
64. Timmerman, L. A., Clipstone, N. A., Ho, S. N., Northrop, J. P. and Crabtree, G. R., Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature 1996. 383: 837-840.
65. Clipstone, N. A. and Crabtree, G. R., Identification of Calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992. 357: 695-697.
66. Liu, J., Farmer Jr, J. D., Lane, W. S., Friedman, J., Weissman, I. and Schreiber, S. L., Calcineurin is a common target of Cyclophilin-Cyclosporin A and FKBP-FK506 complexes. Cell 1991. 66: 807-815.
67. Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T. and Thompson, C. B., CD28 costimulation can promote T cell survival by enhancing the expression of Bel-XL. Immunity 1995. 3: 87-98.
68. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C.-F., Chang, H.-M. and Yeh, T. H., Protection against Fas/Apo-1- and Tumor Necrosis Factor-mediated cell death by a novel protein, Sentrin. J. Immunol. 1996. 157: 4277-4281.
69. Wallach, D., Placing death under control. Nature 1997. 388: 123-126.
70. Alessi, D. R., Caudwell, F. B., Andjelkovic, M., Hemmings, B. A. and Cohen, P., Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 1996. 399: 333-338.
71. Skorski, T., Bellacosa, A., Nieborowska-Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., Wasik, M. A., Tsichlis, P. N. and Calabretta, B., Transformation of hemato-poietic cells by BCR/ABL requires activation of a PI-Sk/ Akt-dependent pathway. EMBO J. 1997. 16: 6151-6161.
72. McGahon, A. J., Nishioka, W. K., Martin, S. J., Mahboubi, A., Cotter, T. G. and Green, D. R., Regulation of the Fas apoptotic cell death pathway by Abl. J. Biol. Chem. 1995. 270: 22625-22631.
73. Kulik, G., Klippel, A. and Weber, M. J., Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 1997. 17: 1595-1606.
74. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N. and Hay, N., The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997. 11: 701-713.
75. Khwaja, A., Rodriguez-Viciana, P., Wennstrom, S., Warne, P. H. and Downward, J., Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 1997. 16: 2783-2793.
76. Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N. and Testa, J. R., AKT2, a putative oncogene encoding a member of a subfamily of protein-serine threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 1992. 89: 9267-9271.
77. Cheng, J. Q., Ruggeri, B., Klein, W. M., Sonoda, G., Altomare, D. A., Watson, D. K. and Testa, J. R., Amplification of AKT2 in human pancreatic-cancer cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. USA 1996. 93: 3636-3641.
78. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium staining and flow cytometry. J. Immunol. Methods 1991. 139: 271-279.
79. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O. and Ui, M., Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 1994. 269: 3653-3667.
80. Stephens, L. R., Hughes, K. T. and Irvine, R. F., Pathway of phosphatidylinositol (3,4,5)-trisphosphate synthesis and activated neutrophils. Nature 1991. 351: 33-39.